SetPoint Medical secures $140 million to launch innovative neuroimmune modulation therapy for rheumatoid arthritis, advancing treatment for autoimmune diseases.
Discover how Orpyx's innovative sensory insoles advance diabetes foot care, enhancing health outcomes and reducing costs through real-time monitoring and support.